SCHEMBL752330

SCHEMBL752330

COc1ccc(CS(=O)(=O)C(I)I)cc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.49
APLNR P35414 2/20 0.47
PLCG1 P19174 1/20 0.45
HTT P42858 2/20 0.44
IDO1 P14902 1/20 0.44
PKM P14618 1/20 0.44
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
CA5A P35218 1/20 0.44
CA14 Q9ULX7 1/20 0.44
F2RL1 P55085 1/20 0.43
KMT2A Q03164 1/20 0.43
SLC6A4 P31645 1/20 0.43
POLB P06746 1/20 0.43
ALDH1A1 P00352 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL171784 0.83 LDHA (0.50) LDHAAPLNRPLCG1HTTIDO1
SCHEMBL752240 0.81 PLCG1 (0.49) LDHAAPLNRPLCG1HTTIDO1
SCHEMBL13926854 0.79 SLC6A4 (0.49) LDHAAPLNRPLCG1HTTCA1
SCHEMBL753837 0.79 KMT2A (0.49) IDO1CA12CA1CA2CA9
SCHEMBL2717301 0.78 KMT2A (0.57) APLNRPLCG1HTTIDO1PKM
SCHEMBL30496480 0.76 PKM (0.56) APLNRPLCG1HTTIDO1PKM
SCHEMBL3237396 0.76 PKM (0.56) APLNRPLCG1HTTIDO1PKM
SCHEMBL294919 0.76 APLNR (0.53) APLNRPLCG1HTTIDO1PKM
Hydrochloric Acid SCHEMBL27633192 0.76 KMT2A (0.55) APLNRPLCG1HTTIDO1PKM
SCHEMBL2377998 0.76 APLNR (0.58) APLNRPLCG1HTTIDO1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2213166-B1 Biocidal compounds containing 2-methylisothiazolin-3-one and a haloalkylsulfone THOR GMBH (DE) 2012-03-21 EP claimed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US claimed
US-8287631-B2 Compounds for preventing ghost odour THOR GMBH (DE) 2012-10-16 US disclosed
US-20100186631-A1 Compounds for preventing ghost odour THOR GMBH (DE) 2010-07-29 US disclosed
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone THOR GMBH (DE) 2010-07-29 US disclosed
US-4018611-A Non-yellowing antimicrobial compositions comprising diiodomethyl sulfones METALORGANA ETABLISSEMENT (FL) 1977-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100189811-A1 Biocide compositions comprising 3-methylisothiazolin-3-one and a haloalkyl sulphone MBTD1, MPST, B2M LDHA 3852/4885APLNR 4576/4885PLCG1 2321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.